ConductScience.org, home

Paper665309

Changes in plasma volume and extracellular fluid volume and after addition of hydralazine to propranolol treatment in patients with hypertension.

Ibsen H and 3 others. Acta Med Scand, 1978. Cited by 32 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Changes in plasma volume and extracellular fluid volume and after addition of hydralazine to propranolol treatment in patients with hypertension. Papers, record 665309. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/665309

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Changes in plasma volume and extracellular fluid volume and after addition of hydralazine to propranolol treatment in patients with hypertension.
PubMed
Journal
Acta Med Scand
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
2.17
iCite
Revised in PubMed
2019-08-12
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ibsen HH
2Rasmussen KK
3Jensen HAH A
4Leth AA

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Extracellular SpaceMajor topic
HydralazineMajor topic
HypertensionMajor topic
Plasma VolumeMajor topic
PropranololMajor topic
Adult
Aged
Drug Evaluation
Drug Therapy, Combination
Female
Humans
Male
Middle Aged

Source PubMed

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
6,653,652Pinacidil, a new vasodilator: pharmacokinetics and pharmacodynamics of a new retarded release tablet in essential hypertension.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6653652PubMed
6,124,423Long-term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoceptor blocking agent.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/6124423PubMed
2,905,154Antihypertensive efficacy of the calcium-antagonist felodipine in patients with persisting hypertension on beta-adrenoceptor blocker therapy. The Canadian Felodipine Study Group.Br J Clin Pharmacol1988https://conductscience.org/library/papers/2905154PubMed
2,876,898Renal effects of pinacidil in hypertensive patients on chronic beta-blocker therapy.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/2876898PubMed
2,487,529Comparison of indapamide and hydrochlorothiazide plus amiloride as a third drug in the treatment of arterial hypertension.Cardiovasc Drugs Ther1989https://conductscience.org/library/papers/2487529PubMed
1,981,681The efficacy and tolerability of long-term felodipine treatment in hypertension. The Scandinavian Multicenter Group.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/1981681PubMed
1,981,020Effects of nifedipine versus hydralazine on sympathetic activity and cardiac function in patients with hypertension persisting on diuretic plus beta-blocker therapy.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/1981020PubMed
520,398Effect of oral labetalol on plasma catecholamines, renin and aldosterone in patients with severe arterial hypertension.Eur J Clin Pharmacol1979https://conductscience.org/library/papers/520398PubMed
477,707Effect of nifedipine on plasma renin, aldosterone and catecholamines in arterial hypertension.Eur J Clin Pharmacol1979https://conductscience.org/library/papers/477707PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/665309

GET https://conductscience.org/api/papers/v1/665309/authors